Comorbidity Drives Genetic Overlap Between Anxiety and Major Depression

Major depressive disorder and anxiety disorders are two of the most significant contributors to global disability, frequently co-occurring in clinical practice [1]. This high rate of comorbidity has long complicated efforts to determine whether they represent distinct pathologies or share a common biological origin [2]. While anxiety disorders can emerge as early as age 5.5 and mood disorders by 20.5, their frequent overlap obscures the underlying genetic architecture [3]. The increasing prevalence of these conditions, particularly following recent public health crises, has intensified the need for more precise diagnostic frameworks [4]. A recent study addresses this challenge by systematically investigating how the inclusion of comorbid cases in genetic analyses may inflate the perceived biological similarity between these two common psychiatric disorders.